tisotumab vedotin-tftv
genmab,seagen
['tivdak', '$sgen', 'seagen', '$gmab']
$gmab $sgen genmab and seagen present data from tisotumab vedotin (tivdak ) clinical development program and additional cervical cancer research at asco 2022 annual meeting 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities